SCHEMBL6923700

SCHEMBL6923700

CCCC(C)n1c(CC)nc2c(-c3ccc(Cl)cc3Cl)n[nH]c(=O)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6740232 0.87 CRHR1 (0.45)
SCHEMBL6732895 0.82
SCHEMBL6732639 0.78
SCHEMBL7034204 0.76
SCHEMBL7032751 0.71
SCHEMBL7819403 0.70
SCHEMBL7036941 0.69
SCHEMBL7036734 0.69
SCHEMBL6929345 0.69 CRHR1 (0.49)
SCHEMBL6742523 0.67 CRHR1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140929-B1 1H-IMIDAZO 4,5-D]PYRIDAZIN-7-ONES, 3H-IMIDAZO 4,5-C]PYRIDIN-4-ONES AND CORRESPONDING THIONES AS CORTICOTROPIN RELEASING FACTOR (CRF) RECEPTOR LIGANDS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-10-15 EP disclosed
US-6518271-B1 1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands BRISTOL-MYERS SQUIBB COMPANY 2003-02-11 US disclosed
US-6271380-B1 TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC, NEUROLOGICAL DISORDERS AS WELL IMMUNOLOGICAL, CARDIOVASCULAR OR HEART-RELATED DISEASES AND COLONIC HYPERSENSITIVITY ASSOCIATED WITH PSYCHOPATHOLOGICAL DISTURBANCE AND STRESS. DUPONT PHARMACEUTICALS COMPANY 2001-08-07 US disclosed